This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Aspergillus fumigatus is a saprophytic filamentous fungus that is the most frequent causal agent of invasive opportunistic mould infections in immunocompromised patients. Currently, the mechanism used by A. fumigatus to survive and cause disease in immunocompromised hosts is not well understood. During mammalian pathogenesis, all pathogenic microbes are exposed to rapidly changing oxygen levels. Oxygen is the critical electron acceptor in aerobic respiration and organisms must possess alternative mechanisms to deal with low oxygen (hypoxic) conditions found at sites of infection in vivo. Dr. Cramer's hypothesis is that A. fumigatus utilizes an alcohol fermentation pathway to survive inflammatory responses found in vivo in pulmonary invasive aspergillosis. This hypothesis is founded on preliminary data from metabolomics studies of A. fumigatus infected murine broncheoalveolar lavages showing the production of ethanol in vivo during fungal infections. Dr. Cramer's lab is exploring whether this alcohol fermentation pathway is important for A. fumigatus to cause disease by creating genetic mutants of A. fumigatus deficient in their ability to respond to low oxygen conditions via the use of an alcohol fermentation pathway. Dr. Cramer's lab has identified the genes and generated mutants deficient in these genes, which are involved in alcohol fermentation in A. fumigatus. In addition, Dr. Cramer is attempting to identify additional mechanisms utilized by this pathogenic mould to adapt to hypoxic microenvironments found at sites of infection. They have identified a novel transcription factor, SrbA, which is mediating A. fumigatus hypoxia adaptation, azole drug resistance, and fungal virulence. The results of this proposal have potential clinical significance via direct manipulation of oxygen levels at sites of fungal infection and also the potential to generate increased efficacy of current antifungal drugs.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
2P20RR020185-06
Application #
7960529
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Project Start
2009-09-25
Project End
2010-05-31
Budget Start
2009-09-25
Budget End
2010-05-31
Support Year
6
Fiscal Year
2009
Total Cost
$134,113
Indirect Cost
Name
Montana State University - Bozeman
Department
Veterinary Sciences
Type
Schools of Earth Sciences/Natur
DUNS #
625447982
City
Bozeman
State
MT
Country
United States
Zip Code
59717
de Jong, Nienke W M; Ramyar, Kasra X; Guerra, Fermin E et al. (2017) Immune evasion by a staphylococcal inhibitor of myeloperoxidase. Proc Natl Acad Sci U S A 114:9439-9444
Guerra, Fermin E; Borgogna, Timothy R; Patel, Delisha M et al. (2017) Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus. Front Cell Infect Microbiol 7:286
Siemsen, Dan W; Dobrinen, Erin; Han, Soo et al. (2016) Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration. Am J Pathol 186:259-69
Guerra, Fermin E; Addison, Conrad B; de Jong, Nienke W M et al. (2016) Staphylococcus aureus SaeR/S-regulated factors reduce human neutrophil reactive oxygen species production. J Leukoc Biol 100:1005-1010
Hedges, Jodi F; Robison, Amanda; Kimmel, Emily et al. (2016) Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue. Infect Immun 84:1815-1825
Zurek, Oliwia W; Pallister, Kyler B; Voyich, Jovanka M (2015) Staphylococcus aureus Inhibits Neutrophil-derived IL-8 to Promote Cell Death. J Infect Dis 212:934-8
Pallister, Kyler B; Mason, Sara; Nygaard, Tyler K et al. (2015) Bovine CCL28 Mediates Chemotaxis via CCR10 and Demonstrates Direct Antimicrobial Activity against Mastitis Causing Bacteria. PLoS One 10:e0138084
Hoyt, Teri R; Dobrinen, Erin; Kochetkova, Irina et al. (2015) B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent. Infect Immun 83:743-58
Prigge, Justin R; Hoyt, Teri R; Dobrinen, Erin et al. (2015) Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice. J Immunol 195:5347-57
Hendricks, Jay M; Lowe, Diana C; Hardy, Michele E (2014) Differential induction of isolated lymphoid follicles in the gut by 18?-glycyrrhetinic acid. PLoS One 9:e100878

Showing the most recent 10 out of 235 publications